E74-like factor inhibition induces reacquisition of hormone sensitiveness decreasing period circadian protein homolog 1 expression in prostate cancer cells

Nunn, 1983, Tripartite structure of the avian erythroblastosis virus e26 transforming gene, Nature, 306, 391, 10.1038/306391a0 Oettgen, 1999, Characterization of ESE-2, a novel ESE-1-related Ets transcription factor that is restricted to glandular epithelium and differentiated keratinocytes, J Biol Chem, 274, 29439, 10.1074/jbc.274.41.29439 Wang, 1992, Evolutionarily conserved ets family members display distinct DNA binding specificities, J Exp Med, 175, 1391, 10.1084/jem.175.5.1391 Wasylyk, 1993, The Ets family of transcription factors, Eur J Biochem, 211, 7, 10.1111/j.1432-1033.1993.tb19864.x Choi, 2009, Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5, Dev Biol, 329, 227, 10.1016/j.ydbio.2009.02.032 Donnison, 2005, Loss of the extraembryonic ectoderm in Elf5 mutants leads to defects in embryonic patterning, Development, 132, 2299, 10.1242/dev.01819 Watson, 2008, Mammary development in the embryo and adult: a journey of morphogenesis and commitment, Development, 135, 995, 10.1242/dev.005439 Bhat, 1990, Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1, Proc Natl Acad Sci U S A, 87, 3723, 10.1073/pnas.87.10.3723 Kola, 1993, The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation, Proc Natl Acad Sci U S A, 90, 7588, 10.1073/pnas.90.16.7588 Xie, 2011, Analysis of differentially expressed genes in LNCaP prostate cancer progression model, J Androl, 32, 170 Oettgen, 2000, PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression, J Biol Chem, 275, 1216, 10.1074/jbc.275.2.1216 Ghadersohi, 2011, Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancer, Prostate, 71, 1178, 10.1002/pros.21333 Turner, 2011, Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression, Prostate, 71, 1723, 10.1002/pros.21389 Sood, 2007, Expression characteristics of prostate-derived ets factor support a role in breast and prostate cancer progression, Hum Pathol, 38, 1628, 10.1016/j.humpath.2007.03.010 Ngan, 2009, Microarray coupled to quantitative RT-PCR analysis of androgen-regulated genes in human LNCaP prostate cancer cells, Oncogene, 28, 2051, 10.1038/onc.2009.68 Shah, 2010, Emerging biological observations in prostate cancer, Expert Rev Anticancer Ther, 10, 89, 10.1586/era.09.161 Lee, 2012, Elf5, hormones and cell fate, Trends Endocrinol Metab, 23, 292, 10.1016/j.tem.2012.02.006 Gutierrez-Hartmann, 2007, Ets transcription factors in endocrine systems, Trends Endocrinol Metab, 18, 150, 10.1016/j.tem.2007.03.002 Lapinskas, 2004, A major site of expression of the Ets transcription factor Elf5 is epithelia of exocrine glands, Histochem Cell Biol, 122, 521, 10.1007/s00418-004-0713-x Zhou, 1998, A novel transcription factor, ELF5, belongs to the ELF subfamily of ETS genes and maps to human chromosome 11p13-15, a region subject to LOH and rearrangement in human carcinoma cell lines, Oncogene, 17, 2719, 10.1038/sj.onc.1202198 Sun, 1997, Rigui, a putative mammalian ortholog of the Drosophila period gene, Cell, 90, 1003, 10.1016/S0092-8674(00)80366-9 Ko, 2006, Molecular components of the mammalian circadian clock, Hum Mol Genet, 15 Spec No 2, R271, 10.1093/hmg/ddl207 Reppert, 2002, Coordination of circadian timing in mammals, Nature, 418, 935, 10.1038/nature00965 Schibler, 2002, A web of circadian pacemakers, Cell, 111, 919, 10.1016/S0092-8674(02)01225-4 Shearman, 2000, Interacting molecular loops in the mammalian circadian clock, Science, 288, 1013, 10.1126/science.288.5468.1013 Fu, 2002, The circadian gene period2 plays an important role in tumor suppression and DNA damage response in vivo, Cell, 111, 41, 10.1016/S0092-8674(02)00961-3 Matsuo, 2003, Control mechanism of the circadian clock for timing of cell division in vivo, Science, 302, 255, 10.1126/science.1086271 Fu, 2003, The circadian clock: pacemaker and tumour suppressor, Nat Rev Cancer, 3, 350, 10.1038/nrc1072 Cao, 2009, A role for the clock gene per1 in prostate cancer, Cancer Res, 69, 7619, 10.1158/0008-5472.CAN-08-4199